Home > Drug Search >
  • company_query: Angimmune
  •   > 
Drug Filter
Category:
chemistry (7) biology (32)
Status:
Approved (5) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (16) Phase Ⅰ (15)
Clinical Stage:
Pending (4) Active (26) Discontinued (4)
Bio-Type:
Coagulation factor (1) Gene therapy (2) CAR T cell therapy (11) Vaccine (3) Microbial extract (1) Animal extract (1) Recombinant cytokines (1) Other recombinant protein (2) Whole antibody (5) ADC (2) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acne (1) Acute lymphoblastic leukaemia (ALL) (3) Acute myeloid Leukemia (AML) (1) Atopic dermatitis (1) Bladder cancer (2) Chronic lymphocytic leukemia (CLL) (3) Cutaneous T cell lymphoma (CTCL) (1) Urogenital cancer (1) Glioblastoma multiforme (1) HBV infection (1) HCV infection (1) Heart failure (2) Alcoholic hepatitis (1) Adult respiratory distress syndrome (ADRS) (1) Facial-wrinkles (1) Leukemia (1) Lung cancer (1) Lymphoma (2) Malignancies (1) Melanoma (2) Haematological disorders (1) Multiple myeloma (MM) (3) Erythropoietic protoporphyria (1) Non-Hodgkin’s lymphoma (NHL) (5) Pancreatic cancer (1) Prostate cancer (1) Pulmonary arterial hypertension (1) Norovirus infections (1) Solid tumours (2) Hodgkin lymphoma (2) Colorectal cancer (1) Venous insufficiency (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Neuroblastoma (3) Autistic disorder (1) Acute Lung Injury (1) Sarcoma (2) Acute ischemic stroke (AIS) (1) Hereditary angioedema (HAE) (1) Hyperhidrosis (2) Gallstone (1) Glioblastoma (2) Plaque psoriasis (1) Bleeding (1) Thrombosis (1) Hearing loss (1) Immunodeficiency disorders (1) Renal failure (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top